Publications dans lesquelles il/elle collabore avec Luis Felipe Callado Hernando (11)
2023
-
Isolation and Differentiation of Neurons and Glial Cells from Olfactory Epithelium in Living Subjects
Molecular Neurobiology, Vol. 60, Núm. 8, pp. 4472-4487
2022
-
Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients
Addiction Biology, Vol. 27, Núm. 6
-
Molecular mechanisms underlying cannabis-induced risk of psychosis
Cannabis and the Developing Brain (Elsevier), pp. 197-242
2020
-
Ribosomal Protein S6 Hypofunction in Postmortem Human Brain Links mTORC1-Dependent Signaling and Schizophrenia
Frontiers in Pharmacology, Vol. 11
2018
-
Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway
Neuropsychopharmacology, Vol. 43, Núm. 10, pp. 2028-2035
-
The endocannabinoid system in mental disorders: Evidence from human brain studies
Biochemical Pharmacology, Vol. 157, pp. 97-107
2016
-
Biased agonism of three different cannabinoid receptor agonists in mouse brain cortex
Frontiers in Pharmacology, Vol. 7, Núm. NOV
2013
-
Antidepressant-like properties of three new α2-adrenoceptor antagonists
Neuropharmacology, Vol. 65, pp. 13-19
-
Chronic effects of cannabinoid drugs on monoaminergic systems and the role of endocannabinoids and cannabinoid receptors in human brain disorders
Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders (Springer New York), pp. 213-238
2009
-
Immunodensity and mRNA expression of A2A adenosine, D 2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: Effect of antipsychotic treatment
Psychopharmacology, Vol. 206, Núm. 2, pp. 313-324
-
Relación del sistema cannabinoide con la fisiopatología y el tratamiento de la depresión
Actualización sobre el potencial terapéutico de los cannabinoides (Sociedad Española de Investigación en Cannabinoides (SEIC)), pp. 257-270